Mustang Bio Investor Relations Material
Latest events
Q1 2025
13 May, 2025
Q2 2024
13 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Mustang Bio Inc
Access all reports
Mustang Bio, Inc. is a biotechnology company focused on the development of cell and gene therapies for the treatment of cancer and rare genetic diseases. The company specializes in advancing innovative approaches such as chimeric antigen receptor (CAR) T-cell therapies and gene editing technologies. The company is headquartered in Worcester, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
MBIO
Country
🇺🇸 United States